TIMI Risk Index and the Benefit of Enoxaparin in Patients with ST-Elevation Myocardial Infarction

American Journal of Medicine

Volumn 120, Issue 11, 2007, Pages 993-998

  Ruff, Christian T ^a   Wiviott, Stephen D ^a   Morrow, David A ^a   Mohanavelu, Satishkumar ^a   Murphy, Sabina A ^a   Antman, Elliott M ^a   Braunwald, Eugene ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Enoxaparin; Fibrinolysis; Myocardial infarction; Prognosis; TIMI Risk Index

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ENOXAPARIN; HEPARIN; RETEPLASE; STREPTOKINASE; TENECTEPLASE;

ADULT; ARTICLE; CAUSE OF DEATH; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEMOGRAPHY; DRUG DOSE REDUCTION; FIBRINOLYSIS; HEART INFARCTION; HEART RATE; HEART RUPTURE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SHOCK; ST SEGMENT ELEVATION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; CAUSE OF DEATH; ENOXAPARIN; FIBRINOLYTIC AGENTS; HEMORRHAGE; HEPARIN; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 35548996765     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2007.08.020     Document Type: Article

References (16)

1. Antman E.M., Morrow D.A., McCabe C.H., et al. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 354 (2006) 1477-1488
2. Antman E.M., Morrow D.A., McCabe C.H., et al. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25). Am Heart J 149 (2005) 217-226
3. Morrow D.A., Antman E.M., Giugliano R.P., et al. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy. Lancet 358 (2001) 1571-1575
4. Wiviott S.D., Morrow D.A., Frederick P.D., et al. Performance of the Thrombolysis In Myocardial Infarction Risk Index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction. J Am Coll Cardiol 44 (2004) 783-789
5. Hanley J.A., and McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143 (1982) 29-36
6. Wiviott S.D., Morrow D.A., Frederick P.D., et al. Application of the Thrombolysis In Myocardial Infarction Risk Index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction. J Am Coll Cardiol 47 (2006) 1553-1558
7. Morrow D.A., Antman E.M., Charlesworth A., et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102 (2000) 2031-2037
8. Lee K.L., Woodlief L.H., Topol E.J., et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation 91 (1995) 1659-1668
9. Normand S.T., Glickman M.E., Sharma R.G., and McNeil B.J. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients. Results from the Cooperative Cardiovascular Project. JAMA 275 (1996) 1322-1328
10. Rouleau J.L., Talajic M., Sussex B., et al. Myocardial infarction patients in the 1990s-their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol 27 (1996) 1119-1127
11. Maseri A., Rebuzzi A.G., and Cianflone D. Need for a composite risk stratification of patients with unstable coronary syndromes tailored to clinical practice. Circulation 96 (1997) 4141-4142
12. Hamm C.W. Risk stratifying acute coronary syndromes: gradient of risk and benefit. Am Heart J 138 1 Pt 2 (1999) S6-S11
13. Cannon C.P. Evidence-based risk stratification to target therapies in acute coronary syndromes. Circulation 106 (2002) 1588-1591
14. Antman E.M., Cohen M., Bernink P.J., et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 284 (2000) 835-842
15. Morrow D.A., Antman E.M., Snapinn S.M., et al. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J 23 (2002) 223-229
16. Lindahl B., Diderholm E., Lagerqvist B., et al. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol 38 (2001) 979-986